Literature DB >> 15917628

Cell-free assay for ubiquitin-independent proteasomal protein degradation.

Chaim Kahana1, Yuval Reiss.   

Abstract

The ATP-dependent degradation of ornithine decarboxylase is an exceptional case whereby a protein is targeted to the 26S proteasome independently of ubiquitin conjugation. Rather, prior association with the polyamine-induced regulatory protein, antizyme, confers susceptibility of ornithine decarboxylase to proteasomal degradation. In this chapter we describe ornithine decarboxylase/antizyme-based in vivo and in vitro systems for the measurement of ATP-dependent, ubiquitin-independent proteasomal degradation, as well as the application of ornithine decarboxylase as a reporter for the targeting of proteins to the 26S proteasome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15917628     DOI: 10.1385/1-59259-895-1:083

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

Review 1.  Proteasome activator 200: the heat is on...

Authors:  Anca F Savulescu; Michael H Glickman
Journal:  Mol Cell Proteomics       Date:  2011-03-09       Impact factor: 5.911

2.  Placing a disrupted degradation motif at the C terminus of proteasome substrates attenuates degradation without impairing ubiquitylation.

Authors:  Omri S Alfassy; Itamar Cohen; Yuval Reiss; Boaz Tirosh; Tommer Ravid
Journal:  J Biol Chem       Date:  2013-03-21       Impact factor: 5.157

3.  Ubiquitin-independent degradation of p53 mediated by high-risk human papillomavirus protein E6.

Authors:  S Camus; S Menéndez; C F Cheok; L F Stevenson; S Laín; D P Lane
Journal:  Oncogene       Date:  2007-01-15       Impact factor: 9.867

4.  A broad-spectrum antiviral molecule, QL47, selectively inhibits eukaryotic translation.

Authors:  Mélissanne de Wispelaere; Margot Carocci; Dominique J Burri; William J Neidermyer; Calla M Olson; Imme Roggenbach; Yanke Liang; Jinhua Wang; Sean P J Whelan; Nathanael S Gray; Priscilla L Yang
Journal:  J Biol Chem       Date:  2019-12-30       Impact factor: 5.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.